logo
Epic Universe: An epic impact

Epic Universe: An epic impact

Travel Weeklya day ago

While Epic Universe has already spurred increased business for travel agencies, they are far from the only ones benefitting: Throughout its construction, the park has produced economic impact to the tune of billions of dollars throughout the country, and it is expected to generate billions more now that it is fully operational. Much of that is in central Florida.
'When a major new park debuts, the entire region benefits,' said Casandra Matej, CEO of Visit Orlando. 'Visitors don't just go to one park — they stay in our hotels and resorts, dine in local restaurants, shop in our stores and explore our diverse attractions. It's truly a rising-tide-lifts-all-boats scenario, from global brands to our small businesses.'
Universal Destinations & Experiences engaged economist Sean Snaith, director of the University of Central Florida's (UCF) Institute for Economic Forecasting, to perform an analysis of Epic's impact locally and nationally. The report found that Epic's five-year economic impact from 2019 to 2023 totaled $44 billion and that the construction of the park generated 65,000 jobs across the country.
Further, in its first year of operation, Epic is expected to generate an economic impact of $2 billion in Florida.
Visit Orlando's Matej called Epic's opening a 'landmark moment' for the region, the most visited in the U.S. with 75.3 million visitors in 2024.
Stays this year are already trending positively: From April to June, hotel bookings were pacing 2.5% ahead of the same period last year, according to Matej. Short-term rental bookings were up 16%.
'For more than five decades, theme parks have played a key role in transforming Orlando from citrus groves into a global tourism destination — driving growth, expanding infrastructure and boosting the local economy,' she said.
Jorge Ridderstaat, associate professor of finance, accounting and econometrics at UCF's Rosen College, said the park's overall economic impact expanded well beyond Florida in its planning and construction phase. Going forward, it will be felt more in Florida and the Orlando area, he said, with an estimated $1 billion in additional tax revenue and nearly 18,000 direct employees. 'The direct and indirect economic impacts are major.' Jorge Ridderstaat, UCF
'There's also an indirect effect, and that's coming from additional restaurants, hotels; and you can even think about banking activities,' Ridderstaat said. 'The direct and indirect impacts are major here.'
Universal's other projects under development may be smaller in scale than Epic but will provide significant economic benefits.
Universal Horror Unleashed, a year-round attraction in Las Vegas, will open this year; the Universal Kids Resort is slated to open in Texas in 2026; and Universal's first theme park in England is set to debut in 2031.
Ridderstaat said the new parks would impact local and national economies as well as motivate other operators to compete.
'Because these technologies being used are very sophisticated, that gives a run on Disney to increase the quality of their product,' he said. 'Because otherwise, you don't catch these types of people who are interested in innovative types of products. I think that's a challenge for the competition.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech
Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech

Yahoo

time33 minutes ago

  • Yahoo

Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech

Eli Lilly has been in the spotlight recently with a 3.96% share price increase over the past month. The selection of RyboDyn Inc. to join Lilly Gateway Labs stands out among recent developments, signaling strengthened research capabilities in precision immunotherapies and potentially bolstering investor confidence. Additionally, the company's legal entanglement with the lawsuit concerning Actos, following a class certification affirmation, highlights ongoing challenges in the pharmaceutical sector. The company's ongoing talks to acquire Verve Therapeutics also show its commitment to growing its gene-editing capabilities. These events have added weight to the broader market's trends. We've identified 2 warning signs for Eli Lilly (1 can't be ignored) that you should be aware of. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. Recent developments at Eli Lilly, such as the RyboDyn Inc. collaboration, have potential implications for its strategic growth, particularly in precision immunotherapies. This aligns with the company's narrative of expanding capabilities in oncology and immunology, indicating possible enhancements in revenue and earnings forecasts over the long term. Additionally, as Eli Lilly progresses with Phase III trials, including those for orforglipron, the anticipated product approvals could bolster revenue avenues by tapping into high-demand markets like diabetes and obesity treatments. Over the past five years, Eli Lilly's total shareholder return was a very large 430.14%, demonstrating substantial long-term growth despite recent underperformance against the US Pharmaceuticals industry, which saw a 8.9% drop over the past year. This impressive five-year return provides context to the company's current position, underscoring a history of robust shareholder value creation. Given the ongoing acquisition talks with Verve Therapeutics and Eli Lilly's significant investment in both manufacturing and R&D, the outlook for future revenue and earnings remains optimistic. However, potential regulatory hurdles and pricing pressures, particularly in the U.S. market, highlight possible challenges. The shares, with a current price of US$775.12, are 21.0% below the analyst consensus target of US$981.63. This discount suggests room for growth, should the company meet or exceed the analyst expectations on revenue and earnings. Learn about Eli Lilly's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:LLY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

Stellantis Evaluates Maserati's Future, Including Potential Sale -- Reuters
Stellantis Evaluates Maserati's Future, Including Potential Sale -- Reuters

Yahoo

time34 minutes ago

  • Yahoo

Stellantis Evaluates Maserati's Future, Including Potential Sale -- Reuters

Stellantis (STLA, Financials) is weighing a possible sale of its luxury brand Maserati as part of a broader strategic review, according to a Reuters report citing two unnamed sources familiar with the matter. Warning! GuruFocus has detected 11 Warning Signs with STLA. The discussions reportedly began before newly appointed CEO Antonio Filosa officially takes the helm. Maserati's future is under review as Stellantis navigates a shrinking U.S. market, Chinese competition, and steep tariffs imposed by President Donald Trump on foreign-made cars and parts. Despite the internal review, a Stellantis spokesperson told Reuters that Maserati is not for sale. McKinsey declined to comment. Maserati's sales fell by over 50% last year to 11,300 units, with no new models currently scheduled for launch. A new business plan is expected once Filosa begins his tenure. Stellantis' board remains split on the brand's futuresome directors reportedly view Maserati as a reputational asset, while others believe it lacks viability for a sustainable relaunch. Analysts say streamlining Stellantis' 14-brand portfolio could improve profit margins. The company's shares have lost roughly two-thirds of their value since March 2024. Chinese automakers such as Chery could emerge as potential buyers, echoing earlier moves like Geely's acquisition of Volvo or SAIC's purchase of MG. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

How Advisors Can Avoid Becoming Over-Reliant on AI
How Advisors Can Avoid Becoming Over-Reliant on AI

Yahoo

time34 minutes ago

  • Yahoo

How Advisors Can Avoid Becoming Over-Reliant on AI

Apparently there's no AI in team. Artificial intelligence is being hailed as a key element of the fourth industrial revolution, and new tools are now assisting financial advisors with taking notes, drafting emails, and brainstorming thought leadership content. In fact, the vast majority of advisors said generative AI helped their practices, according to a survey earlier this year. But AI isn't a silver bullet. It lacks emotional intelligence and a human touch. Advisors risk damaging client relationships if they become too reliant on automation — even for routine tasks. 'AI is poor at empathy so far,' said Adrian Johnstone, CEO of the CRM platform Practifi. 'Advisors need to recognize where the personal connection is most powerful, and use AI to automate and alleviate the lesser functions.' READ ALSO: What the GENIUS Act Means for Stablecoins and Advisors and Why UBS Is the Only Wirehouse to Allow Podcasting Today, most advisors use AI to boost meeting efficiency and streamline workflows. Ideally, this frees up more time to spend with clients, but misusing these tools can backfire. 'The common refrain of disaffected clients is: 'I pay you to understand me, my goals, and my fears, not to outsource me to a machine,'' Johnstone said. Wealth management is built on bespoke service, but AI hasn't yet learned to fully adapt to individual client needs and goals. While tools that draft emails and website content are improving, the output still reads 'hollow and generic,' Johnstone warned. Use it or Lose it. Client-facing AI tools can be 'extremely risky' because they can't interpret emotional undertones of client's concerns, said Rafael Loureiro, CEO of an estate planning platform. Still, AI can be useful for quick, factual tasks. 'If it's midnight on a Sunday and a client asks, 'What was my marginal tax rate last year?' that's a perfect use case,' Loureiro said. 'It's not doing financial planning, but answering factual questions.' Everything in Moderation. This isn't the first time new tech or strategies meant to disrupt the wealth management industry have wound up causing trouble for advisors and their clients. Will Trout, director at Datos Insights, pointed to the 2008 financial crisis as a warning. 'Firms that over-relied on risk models without human oversight suffered catastrophic losses,' he told Advisor Upside. This post first appeared on The Daily Upside. To receive financial advisor news, market insights, and practice management essentials, subscribe to our free Advisor Upside newsletter. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store